Concepedia

Lina Inagaki

LI

Statistics

Publications

10

Citations

458

H-Index

10

Active since

2015

Affiliations

Japanese Foundation For Cancer Research(Current)

National Cancer Center Hospital East

Kobe University Hospital

Eisai (Japan)

Eisai (United States)

Lina Inagaki is an author at Japanese Foundation For Cancer Research specializing in oncology, medicine, and toxicity management.

Publications per year

2015–2023

10

Publications

10

Lenvatinib for Anaplastic Thyroid Cancer

Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki et al. · Frontiers in Oncology · 2017 · 192 citations · Full text

, , +12

A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer

Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki et al. · Future Oncology · 2019 · 140 citations · Full text

, , +16

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer

Yoon Ming Chin, Tomoko Shibayama, Ting Chan et al. · Cancer Science · 2022 · 28 citations · Full text

, , +17

Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.

Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki et al. · Journal of Clinical Oncology · 2016 · 27 citations

, , +14

Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Kenji Nakano, Yasuyoshi Sato, Takashi Toshiyasu et al. · Molecular and Clinical Oncology · 2015 · 18 citations · Full text

, , +14

1–5 of 10